170 related articles for article (PubMed ID: 24007528)
1. Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis.
Shi L; Chen J; Zhong Q; Li M; Geng P; He J; Han Z; Sheng M; Tang H
J Transl Med; 2013 Sep; 11():205. PubMed ID: 24007528
[TBL] [Abstract][Full Text] [Related]
2. [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice].
Shi L; Chen J; Zhong Q; Geng P; He J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):177-82. PubMed ID: 24785276
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
Kurooka M; Kaneda Y
Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
[TBL] [Abstract][Full Text] [Related]
4. [Anticancer immunotherapy using inactivated Sendai virus particles].
Kurooka M; Kaneda Y
Uirusu; 2007 Jun; 57(1):19-27. PubMed ID: 18040151
[TBL] [Abstract][Full Text] [Related]
5. Inactivated Sendai virus strain Tianjin induces apoptosis in human breast cancer MDA-MB-231 cells.
Chen J; Han H; Chen M; Xu XZ; Wang B; Shi LY
Asian Pac J Cancer Prev; 2014; 15(12):5023-8. PubMed ID: 24998581
[TBL] [Abstract][Full Text] [Related]
6. Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression.
Zhang Q; Yuan WF; Zhai GQ; Zhu SY; Xue ZF; Zhu HF; Xu XM
Biomed Environ Sci; 2012 Oct; 25(5):509-16. PubMed ID: 23122307
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.
Shi LY; Han Z; Li XX; Li M; Han H; Chen J; Zang S
Cancer Biother Radiopharm; 2015 Feb; 30(1):33-40. PubMed ID: 25517620
[TBL] [Abstract][Full Text] [Related]
8. Inactivated Sendai virus strain Tianjin induces apoptosis and autophagy through reactive oxygen species production in osteosarcoma MG-63 cells.
Han Z; Li Q; Sun S; Zhao W; Shi L
J Cell Physiol; 2019 Apr; 234(4):4179-4190. PubMed ID: 30146726
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effect of inactivated Sendai virus strain Tianjin on human osteosarcoma HOS cells.
Li Q; Ma H; Sun S; Shi L
Gen Physiol Biophys; 2019 Jul; 38(4):335-342. PubMed ID: 31219428
[TBL] [Abstract][Full Text] [Related]
10. Inactivated Tianjin strain, a novel genotype of Sendai virus, induces apoptosis in HeLa, NCI-H446 and Hep3B cells.
Chen J; Han H; Wang B; Shi L
Oncol Lett; 2016 Jul; 12(1):49-56. PubMed ID: 27347098
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
[TBL] [Abstract][Full Text] [Related]
12. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
13. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites.
Sugiyama M; Kakeji Y; Tsujitani S; Harada Y; Onimaru M; Yoshida K; Tanaka S; Emi Y; Morita M; Morodomi Y; Hasegawa M; Maehara Y; Yonemitsu Y
Mol Cancer Ther; 2011 Mar; 10(3):540-9. PubMed ID: 21209070
[TBL] [Abstract][Full Text] [Related]
15. An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells.
He XZ; Wang L; Zhang YY
World J Gastroenterol; 2008 Jan; 14(4):532-40. PubMed ID: 18203284
[TBL] [Abstract][Full Text] [Related]
16. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
[TBL] [Abstract][Full Text] [Related]
17. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
Furumoto K; Soares L; Engleman EG; Merad M
J Clin Invest; 2004 Mar; 113(5):774-83. PubMed ID: 14991076
[TBL] [Abstract][Full Text] [Related]
18. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
Fan W; Tian XD; Huang E; Zhang JJ
Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
[TBL] [Abstract][Full Text] [Related]
19. Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice.
Gou HF; Huang J; Shi HS; Chen XC; Wang YS
PLoS One; 2014; 9(1):e85789. PubMed ID: 24465710
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells coinjected with tumor cells treated with an anticancer drug to induce tumor rejection.
Inoue N; Yamasaki S; Kondo K; Kan T; Furumoto K; Imamura M
Surg Today; 2003; 33(4):269-76. PubMed ID: 12707821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
